Irbesartan precautionary recalls

Recall: 6 February 2019

Precautionary Pharmacy Level Recall of One Batch of Irprestan (Irbesartan) 150mg Tablets by Accord/Actavis

Pharmacists are advised that, as part of the ongoing EU-wide review of the sartan impurity issue, Accord/Actavis is recalling one batch of lrprestan (lrbesartan) 150mg film-coated tablets to pharmacy level.

Accord Recall Letter for Wholesalers - 6 February 2019

A copy of the recall letter which has been sent to medicines wholesalers is also provided below for information:
Accord Recall Letter for Wholesalers - 6 February 2019


Recall: 1 December 2018

Precautionary Pharmacy Level Recall of Two Batches of Irprezide (Irbesartan / Hydrochlorothiazide) Tablets by Teva

Pharmacists are advised that, as part of the ongoing EU-wide review of the sartan impurity issue, Teva is recalling two batches of lrprezide (lrbesartan/Hydrochlorothiazide) 150mg/12.5mg and 300mg/12.5mg tablets to pharmacy level.

To assist pharmacists with this recall, the HPRA issued an Advance Notice yesterday afternoon via the PSI. A copy of the recall letter which is being sent by Teva to pharmacists is also available below for information: 

Teva lrprezide - Pharmacy Recall Letter - 21 December 2018
  
A copy of the recall letter which is being sent by Teva to medicines wholesalers is also provided below for information:

Teva lrprezide - Recall Letter for Wholesalers - 21 December 2018